411 related articles for article (PubMed ID: 27760825)
1. Gli Transcription Factors Mediate the Oncogenic Transformation of Prostate Basal Cells Induced by a Kras-Androgen Receptor Axis.
Wu M; Ingram L; Tolosa EJ; Vera RE; Li Q; Kim S; Ma Y; Spyropoulos DD; Beharry Z; Huang J; Fernandez-Zapico ME; Cai H
J Biol Chem; 2016 Dec; 291(49):25749-25760. PubMed ID: 27760825
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.
Li N; Chen M; Truong S; Yan C; Buttyan R
Prostate; 2014 Oct; 74(14):1400-10. PubMed ID: 25132524
[TBL] [Abstract][Full Text] [Related]
3. Loss of the transcription factor GLI1 identifies a signaling network in the tumor microenvironment mediating KRAS oncogene-induced transformation.
Mills LD; Zhang Y; Marler RJ; Herreros-Villanueva M; Zhang L; Almada LL; Couch F; Wetmore C; Pasca di Magliano M; Fernandez-Zapico ME
J Biol Chem; 2013 Apr; 288(17):11786-94. PubMed ID: 23482563
[TBL] [Abstract][Full Text] [Related]
4. GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state.
Nadendla SK; Hazan A; Ward M; Harper LJ; Moutasim K; Bianchi LS; Naase M; Ghali L; Thomas GJ; Prowse DM; Philpott MP; Neill GW
PLoS One; 2011; 6(5):e20271. PubMed ID: 21633508
[TBL] [Abstract][Full Text] [Related]
5. Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model.
Chang HH; Chen BY; Wu CY; Tsao ZJ; Chen YY; Chang CP; Yang CR; Lin DP
J Biomed Sci; 2011 Jan; 18(1):6. PubMed ID: 21241512
[TBL] [Abstract][Full Text] [Related]
6. Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells.
Chen M; Feuerstein MA; Levina E; Baghel PS; Carkner RD; Tanner MJ; Shtutman M; Vacherot F; Terry S; de la Taille A; Buttyan R
Mol Cancer; 2010 Apr; 9():89. PubMed ID: 20420697
[TBL] [Abstract][Full Text] [Related]
7. Non-canonical activation of hedgehog in prostate cancer cells mediated by the interaction of transcriptionally active androgen receptor proteins with Gli3.
Li N; Truong S; Nouri M; Moore J; Al Nakouzi N; Lubik AA; Buttyan R
Oncogene; 2018 Apr; 37(17):2313-2325. PubMed ID: 29429990
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase inhibitor SU6668 attenuates positive regulation of Gli proteins in cancer and multipotent progenitor cells.
Piirsoo A; Kasak L; Kauts ML; Loog M; Tints K; Uusen P; Neuman T; Piirsoo M
Biochim Biophys Acta; 2014 Apr; 1843(4):703-14. PubMed ID: 24418624
[TBL] [Abstract][Full Text] [Related]
9. GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism.
Tong W; Qiu L; Qi M; Liu J; Hu K; Lin W; Huang Y; Fu J
J Cell Biochem; 2018 Apr; 119(4):3641-3652. PubMed ID: 29231999
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling.
Sanchez P; Hernández AM; Stecca B; Kahler AJ; DeGueme AM; Barrett A; Beyna M; Datta MW; Datta S; Ruiz i Altaba A
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12561-6. PubMed ID: 15314219
[TBL] [Abstract][Full Text] [Related]
11. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
12. Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.
Regl G; Kasper M; Schnidar H; Eichberger T; Neill GW; Philpott MP; Esterbauer H; Hauser-Kronberger C; Frischauf AM; Aberger F
Cancer Res; 2004 Nov; 64(21):7724-31. PubMed ID: 15520176
[TBL] [Abstract][Full Text] [Related]
13. A Critical Function for the Transcription Factors GLI1 and GLI2 in the Proliferation and Survival of Human Mast Cells.
Falduto GH; Pfeiffer A; Zhang Q; Yin Y; Metcalfe DD; Olivera A
Front Immunol; 2022; 13():841045. PubMed ID: 35251038
[TBL] [Abstract][Full Text] [Related]
14. Targeting GLI1 and GLI2 with small molecule inhibitors to suppress GLI-dependent transcription and tumor growth.
Maresca L; Crivaro E; Migliorini F; Anichini G; Giammona A; Pepe S; Poggialini F; Vagaggini C; Giannini G; Sestini S; Borgognoni L; Lapucci A; Dreassi E; Taddei M; Manetti F; Petricci E; Stecca B
Pharmacol Res; 2023 Sep; 195():106858. PubMed ID: 37473878
[TBL] [Abstract][Full Text] [Related]
15. β
Zhang M; Wang Q; Sun X; Yin Q; Chen J; Xu L; Xu C
Prostate; 2020 Nov; 80(15):1328-1340. PubMed ID: 32894788
[TBL] [Abstract][Full Text] [Related]
16. GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression.
Tolosa EJ; Fernandez-Barrena MG; Iguchi E; McCleary-Wheeler AL; Carr RM; Almada LL; Flores LF; Vera RE; Alfonse GW; Marks DL; Hogenson TL; Vrabel AM; Horn IP; Koenig AN; Safgren SL; Sigafoos AN; Erkan M; Romecin-Duran PA; Sarabia Gonzalez A; Zhou B; Javelaud D; Marsaud V; Graham RP; Mauviel A; Elsawa SF; Fernandez-Zapico ME
Biochem J; 2020 Sep; 477(17):3131-3145. PubMed ID: 32766732
[TBL] [Abstract][Full Text] [Related]
17. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation.
Nolan-Stevaux O; Lau J; Truitt ML; Chu GC; Hebrok M; Fernández-Zapico ME; Hanahan D
Genes Dev; 2009 Jan; 23(1):24-36. PubMed ID: 19136624
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63α enhances the oncogenic phenotype of osteosarcoma cells by inducing the expression of GLI2.
Ram Kumar RM; Betz MM; Robl B; Born W; Fuchs B
BMC Cancer; 2014 Aug; 14():559. PubMed ID: 25085524
[TBL] [Abstract][Full Text] [Related]
19. Stromal Gli signaling regulates the activity and differentiation of prostate stem and progenitor cells.
Li Q; Alsaidan OA; Rai S; Wu M; Shen H; Beharry Z; Almada LL; Fernandez-Zapico ME; Wang L; Cai H
J Biol Chem; 2018 Jul; 293(27):10547-10560. PubMed ID: 29773652
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
Schnidar H; Eberl M; Klingler S; Mangelberger D; Kasper M; Hauser-Kronberger C; Regl G; Kroismayr R; Moriggl R; Sibilia M; Aberger F
Cancer Res; 2009 Feb; 69(4):1284-92. PubMed ID: 19190345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
